Clinical trial
A Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy Subjects
NCT06303648 is registered in ClinicalTrials.gov with Transcend Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy Subjects
- Lead sponsor
- Transcend Therapeutics
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 20, 2024
- Completion date
- July 13, 2025
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
post traumatic stress disorder